Dear customers,
we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
ESCV 2022
Interview: Tuberculosis Diagnostics at R-Biopharm
“Early and consistent tuberculosis detection to break infection chains and eliminate the disease worldwide” R-Biopharm has launched a new generation of diagnostics for the global [...]
32nd Annual Meeting of the Society for Virology
R-Biopharm announces quality products distribution agreement with Microbix
Mississauga, Canada and Darmstadt, Germany, 15th May 2020 – R-Biopharm AG and Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator, announces the appointment of R-Biopharm [...]
Systems
R-Biopharm launches new generation of RIDA®UNITY
We are proud to present you today the new generation of the RIDA® UNITY system. RIDA®UNITY, now with 4 real time PCR cyclers, stands for efficiently generated accurate results in molecular [...]